Navigation Links
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Date:4/24/2012

DURHAM, N.C., April 24, 2012 /PRNewswire/ -- Argos Therapeutics Inc. today announced that it has secured a $25 million Series D financing to support the commencement of its Phase 3 ADAPT study in patients with newly diagnosed, metastatic renal cell carcinoma (mRCC) in mid-2012. The financing was led by Forbion Capital and included other existing investors, including TVM Capital, Lumira Capital, Intersouth Partners, Caisse de depot et placement du Quebec, Morningside Group, and Aurora Funds. Argos's Arcelis™ immunotherapy, AGS-003, has also been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with mRCC.  The international Phase 3 ADAPT study is expected to commence in mid-2012 under a revised Special Protocol Assessment (SPA) agreement with the FDA. This pivotal study will evaluate the addition of AGS-003 to standard therapy versus standard therapy alone.

"With this latest round of financing Argos is well positioned to execute its business strategy and move forward with the planned Phase 3 ADAPT study of its lead product candidate, AGS-003," said Jeff Abbey, president and chief executive officer of Argos. "We recently presented updated results at the 2012 ASCO Genitourinary Cancers Symposium from a Phase 2 study of AGS-003 demonstrating prolonged survival in newly diagnosed, metastatic RCC patients.  Importantly, we also demonstrated that our intended mechanism of action, the induction of memory T cells, significantly correlated with improved overall survival.  The Phase 3 ADAPT study is designed to confirm these positive results and demonstrate that AGS-003 may be an effective, safe and readily combinable therapeutic option for patients with metastatic RCC."

Charles Nicolette, Ph.D., chief scientific officer and vice president of research and development of Argos, said, "The Fast Track designation by the FDA recogniz
'/>"/>

SOURCE Argos Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
2. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
3. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
4. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
5. Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
6. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
7. Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  A substantial share ... decisions about which therapies are included in formularies—say ... according to a new Manhattan Research study, ... The study finds that P&T committee members in ... managers (PBMs) have set a high bar for ...
(Date:7/31/2014)... , July 31, 2014 Lazarus Effect, ... novel interventional devices to facilitate removal of blood clots, ... from the financing will support EU commercialization of several ... for the Lazarus ReCover™ and Lazarus Cover™ in ... financing reflects investor confidence in the value of our ...
(Date:7/31/2014)... -- For its innovative modular Biomedical Research building in ... has earned a Modular Building Institute (MBI) 2014 Award ... categories, MBI,s contest is the commercial modular industry,s premier ... dealers, and product and service providers. ... our team," said Dan Palmer , President of ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... Incorporated (Nasdaq: ARAY ), a global leader ... company has established a Medical Affairs function to accelerate ... provide strategic guidance on clinically driven processes, innovations and ... Accuray has been focused on driving innovation that meets ...
... Millennium Pharmacy Systems, Inc. has announced that Philip ... Vice President and Chief Operating Officer based in its ... 29, 2010. Mr. Keough brings over twenty ... consulting experience to Millennium. He most recently led Keoco, ...
Cached Medicine Technology:Accuray Establishes Medical Affairs Function 2Accuray Establishes Medical Affairs Function 3Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as COO 2
(Date:7/31/2014)... Adventist Health System, which is ... Florida Hospital Tampa, Florida Hospital Carrollwood, Florida Hospital ... Pinellas, Florida Hospital Wesley Chapel, Florida Hospital Zephyrhills, ... Heartland Medical Center Lake Placid and Florida Hospital ... Most Wired Hospitals and Health Systems, which is ...
(Date:7/31/2014)... The vineyards are lush, and the grapes ... to celebrate, folks are gearing up for the annual ... 7, 2014 along the Leelanau Peninsula Wine Trail . ... run through the vineyards start-ing at 9:00 a.m. on Saturday ... course between rows of grapevines offers an experience like no ...
(Date:7/31/2014)... 2014 Weblify has finally been released by ... development and testing. The result is a perfected and ... little as 5 minutes without knowing any HTML or other ... Shane Michaels, an SEO expert, agrees that this platform allows ... a lot of web site builders out there, but this ...
(Date:7/31/2014)... 2014 United Theological Seminary is pleased ... Le Donne and Peter J. Bellini. Both began their ... United is a Director of Non-Degree Programs, Mark Abbott, ... Anthony Le Donne, Assistant Professor of New Testament, received ... New Testament, Second Temple Judaism, and Greek courses. His ...
(Date:7/31/2014)... NEWwoodworks, fine woodworking group at ... presence with a website dedicated to highlighting their craft ... specialized in handcrafted cabinetry, furniture, stairs , doors, ... a reputation for taking on the remarkable, challenging projects ... craft with reclaimed wood, often using near extinct species ...
Breaking Medicine News(10 mins):Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers a Unique Vineyard Course for Walkers, Runners and Wine Tasters 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3Health News:Growing Seminary Welcomes New Faculty 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3
... ... informs consumers how to dispute inaccuracies in their credit file , ... Delray Beach, FL (PRWEB) February 9, ... today announced the importance of ensuring a clean credit report and reminds consumers of ...
... should consider preventive measures, study suggests , TUESDAY, Feb. 9 ... much more likely to develop blood clots than people without ... make preventive drug treatment necessary, it adds. , The study, ... who had inflammatory bowel disease (IBD) with 71,672 people who ...
... ... Exploration Summer Programs , open to students around the world, is offering ... 6 to 9, providing an in-depth experience in the culinary arts, emergency ... Exploration Focus Programs will give kids an opportunity to spend ...
... , ... Heart Association’s Go Red For Women® Movement to Fight Heart Disease in Eastern Washington ... Eastern Washington ... Walla Walla, Clarkston, Hermiston, OR, Lewiston, ID announce their participation in year three of ...
... Mich. , Feb. 9 People with depression ... even when they are treated with antidepressants, according to a ... Environmental Medicine. , The study, led by researchers from ... data for more than 22,000 patients diagnosed with depression and ...
... ... applications in iTunes, Healthcare & Fitness category , ... San Francisco (PRWEB) February 9, 2010 -- Abvio demonstrates the ... and Walkmeter , at Macworld 2010 . All three are among the top ...
Cached Medicine News:Health News:NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010 2Health News:Inflammatory Bowel Ups Risk for Blood Clots 2Health News:Time to 'Get Focused' at Exploration Summer Programs 2Health News:Time to 'Get Focused' at Exploration Summer Programs 3Health News:Time to 'Get Focused' at Exploration Summer Programs 4Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 2Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 3Health News: Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 4Health News:Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study 2Health News:Media Alert: Abvio Demonstrates Innovative iPhone 3G/3GS Fitness Applications for Running, Cycling and Walking at Macworld 2010 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: